The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Real world evidence of systemic therapy in hormone receptor positive advanced breast cancer (HR+ ABC) in Australia: ARORA Registry.
 
Sheau Wen Lok
Research Funding - AstraZeneca (Inst); Novartis (Inst)
Patents, Royalties, Other Intellectual Property - Receive annual royalties from my institution (Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia) for sale of patent for venetoclax
 
Iris Tung
No Relationships to Disclose
 
Angelyn Anton
Honoraria - Amgen; Eisai; Janssen-Cilag
Consulting or Advisory Role - Amgen
Research Funding - Amgen (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Janssen (Inst); MSD (Inst); Mundipharma (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Janssen
 
Sally E. Baron-Hay
Consulting or Advisory Role - AstraZeneca; Eisai; GlaxoSmithKline; Merck Sharpe and Doehme; Novartis; Pfizer; Roche
Speakers' Bureau - MSD Oncology
Travel, Accommodations, Expenses - Gilead Sciences; MSD Oncology
 
Richard H. De Boer
Honoraria - AstraZeneca; Gilead Sciences; Lilly; Novartis; Pfizer; Roche
Consulting or Advisory Role - AstraZeneca; Gilead Sciences; Lilly; Novartis
Travel, Accommodations, Expenses - Gilead Sciences
 
Frances M. Boyle
Honoraria - Eisai; Gilead Sciences; Lilly; Roche
Consulting or Advisory Role - Gilead Sciences; Lilly; Novartis; Pfizer; Roche
Expert Testimony - Gilead Sciences; Lilly
Travel, Accommodations, Expenses - Novartis
Other Relationship - Clinical Oncology Society of Australia (COSA); Pamgene; Paxman
(OPTIONAL) Uncompensated Relationships - Paxman; Paxman
 
Ian M. Collins
No Relationships to Disclose
 
Katharine Cuff
Consulting or Advisory Role - Novartis
Travel, Accommodations, Expenses - AstraZeneca
 
Lucy Gately
Stock and Other Ownership Interests - Telix Pharmaceuticals (I)
Research Funding - Bayer (Inst)
 
Chloe L. Georgiou
No Relationships to Disclose
 
Sally Greenberg
No Relationships to Disclose
 
Bhaskar Karki
No Relationships to Disclose
 
Louise M. Nott
No Relationships to Disclose
 
Michelle K. Nottage
No Relationships to Disclose
 
Natalie Rainey
Consulting or Advisory Role - Lilly; MSD Oncology
Other Relationship - MSD Oncology; Pfizer
 
Javier Torres
No Relationships to Disclose
 
Belinda Jane Yeo
Consulting or Advisory Role - AstraZeneca; Gilead Sciences; Lilly; Novartis
Speakers' Bureau - AstraZeneca; Gilead Sciences
Travel, Accommodations, Expenses - AstraZeneca; Novartis
 
Peter Gibbs
Honoraria - Amgen; Merck; MSD Oncology; Roche; SERVIER
Consulting or Advisory Role - Haystack Oncology
Research Funding - Amgen (Inst); Bayer (Inst); Bristol-Myers Squibb/Sanofi (Inst); Merck Serono (Inst); Pierre Fabre (Inst); Roche (Inst); Roche Molecular Diagnostics (Inst); Servier (Inst)
Travel, Accommodations, Expenses - Servier
 
Vanessa Wong
Honoraria - Amgen; Janssen